Pazopanib hydrochloride

pazopanib · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for Pazopanib hydrochloride, covering 2013-08-12 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors [Phase 1]